Sanofi in talks to sell generics arm Zentiva to Advent for 1.9 bln euros

PARIS, April 17 (Reuters) - French healthcare group Sanofi
has started exclusive talks with private equity firm
Advent International over selling its Zentiva European generics
drugs arm to Advent for 1.9 billion euros ($2.4 billion), the
companies said.

Top News